<DOC>
	<DOCNO>NCT03078972</DOCNO>
	<brief_summary>This study evaluate cardiovascular system interact mechanical heart provide blood flow body exercise . Two aim propose : 1 ) determine impact mechanical heart exercise pressor reflex heart failure patient ; 2 ) define primary determinant ( ) exercise capacity heart failure patient device implantation .</brief_summary>
	<brief_title>Effect mechanIcal circulatoRy Support ON Exercise Capacity aMong pAtieNts With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Advanced Heart Failure Individuals severely reduce left ventricular systolic function schedule undergo LVAD insertion uncontrolled diabetes peripheral neuropathy ( interferes acquisition MSNA signal ) Individuals clinical right ventricular failure , define moderateseverely reduce RV systolic function echocardiography , clinical evidence RV failure ( elevated jugular venous pressure , significant peripheral edema ) Individuals moderatesevere preexist aortic insufficiency , patient typically undergo Park stitch time CFLVAD insertion permanently close aortic valve prevent worsen aortic insufficiency ; Disorders adversely influence exercise ability ( e.g . arthritis , peripheral vascular disease , pulmonary disease ) Mild Heart Failure Individuals medically manage leave ventricular systolic function NOT schedule undergo LVAD insertion HF patient ejection fraction &lt; 3540 % Individuals require systemic anticoagulation vitaminK antagonist new/direct oral anticoagulant ( `` NOAC '' / '' DOAC '' ) Disorders adversely influence exercise ability ( e.g . arthritis , peripheral vascular disease , pulmonary disease ) History uncontrolled arrhythmia ( e.g . ventricular tachycardia nonsustained ventricular tachycardia ) . Healthy Controls Persons without past medical history cardiovascular disease relate disease ( e.g . hypertension , diabetes , peripheral vascular disease , arrhythmia , stroke/transient ischemic attack ) take cardiacrelated medication ( e.g . antihypertensive medication ) Individuals require systemic anticoagulation vitaminK antagonist new/direct oral anticoagulant ( `` NOAC '' / '' DOAC '' ) Disorders adversely influence exercise ability ( e.g . arthritis , peripheral ascular disease ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>